Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Performance comparison of NextSeq and Ion Proton platforms for molecular diagnosis of clinical oncology.

Tumori - 12 May 2017

Cao Fei, Gao Lianju, Wei Longgang, Chen Zhanni, Wang Yan, Ran Xia, Meng Xuehong, Tao Ji

Abstract excerpt

PURPOSE: Next-generation sequencing is a powerful approach to detect genetic mutations with which cancer diagnosis and treatment can be tailored to the individual patient in the era of personalized and precision medicine. Ion Torrent Systems Ion Proton and Illumina NextSeq are 2 major targeted sequencing platforms; however, not much work has been done to compare these platforms' performance for mutation detection...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to High-Throughput Nucleotide Sequencing
Share to INDEL Mutation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Medical Oncology

Share to Molecular Diagnostic Techniques

Share to Neoplasm Proteins

Share to Neoplasms

Share to Polymorphism, Single Nucleotide

Share to Protons

Source

Identifiers

PMID: 28127742
DOI: 10.5301/tj.5000600

Genes

MAF

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Performance comparison of NextSeq and Ion Proton platforms for molecular diagnosis of clinical oncology.PMID 28127742Read ↗

Clinical massively parallel next-generation sequencing analysis of 409 cancer-related genes for mutations and copy number variations in solid tumours.Semantic proximity Read ↗

Versatile ion S5XL sequencer for targeted next generation sequencing of solid tumors in a clinical laboratory.Semantic proximity Read ↗

Optimizing an ion semiconductor sequencing data analysis method to identify somatic mutations in the genomes of cancer cells in clinical tissue samples.Semantic proximity Read ↗

Comparison of Next-Generation Sequencing Panels and Platforms for Detection and Verification of Somatic Tumor Variants for Clinical Diagnostics.Semantic proximity Read ↗

A Targeted High-Throughput Next-Generation Sequencing Panel for Clinical Screening of Mutations, Gene Amplifications, and Fusions in Solid Tumors.Semantic proximity Read ↗

Targeted Next Generation Sequencing as a Reliable Diagnostic Assay for the Detection of Somatic Mutations in Tumours Using Minimal DNA Amounts from Formalin Fixed Paraffin Embedded Material.Semantic proximity Read ↗

A targeted next-generation sequencing method for identifying clinically relevant mutation profiles in lung adenocarcinoma.Semantic proximity Read ↗

Performance Characteristics of a Targeted Sequencing Platform for Simultaneous Detection of Single Nucleotide Variants, Insertions/Deletions, Copy Number Alterations, and Gene Fusions in Cancer Genome.Semantic proximity Read ↗

Development and evaluation of ActSeq: A targeted next-generation sequencing panel for clinical oncology use.Semantic proximity Read ↗

[Comparison of different massive parallel sequencing platforms for mutation profiling in formalin-fixed and paraffin-embedded samples].Semantic proximity Read ↗

Next-generation sequencing with emphasis on Illumina and Ion torrent platforms.Semantic proximity Read ↗

Technical feasibility of a long read, fourth generation sequencing platform in diagnostic profiling of clinical routine samples: a proof-of-concept study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.